Signalisation et Régulations Cellulaires, Institut de Biochimie et de Biophysique Moléculaire et Cellulaire, Unité Mixte de Recherche 8619, Centre National de la Recherche Scientifique,Université Paris-Sud XI, 91405 Orsay, France.
Cell Signal. 2011 Dec;23(12):1997-2004. doi: 10.1016/j.cellsig.2011.07.010. Epub 2011 Jul 22.
Sphingosine 1-phosphate (S1P), a bioactive lipid generated by sphingosine kinases (SphK1/2), initiates different signalling pathways involved in physiological and pathological processes. We previously demonstrated that in rat myometrium at late (day 19) gestation, SphK1 increases the expression of COX2 via S1P generation and release. In rat uterine leiomyoma cells (ELT3), SphK1/S1P axis controls survival and proliferation. In the present study we demonstrate that PDBu activates SphK1 but not SphK2. SphK1 activation requires PKC and MAPK ERK1/2. S1P produced by PDBu is released in the medium. PDBu-induced S1P export is abolished by Ro-318220 and BIM (PKC inhibitors), by U0126 and PD98059 (MEK inhibitors), SKI-II (SphKI/2 inhibitor) and SphK1-siRNA, suggesting the involvement of PKC, ERK and SphK1 respectively. The release of S1P is insensitive to inhibitors of ATP Binding Cassette (ABC)A1 and ABCB1 transporters, but is abolished when ABCC1 transporters are inhibited by MK571 or down-regulated by ABCC1-siRNA. PDBu increases COX2 expression that is blocked by the inhibition of PKC, ERK1/2, SphK1, and when cells are treated with MK571 or transfected with ABCC1-siRNA. The induction of COX2 by the S1P release due to PDBu or by exogenous S1P involves S1P2 receptors coupled to Gi. In myometrium from rat at late gestation, the release of S1P is also strongly reduced when SphK and ABCC1 are inhibited. The data reveal that in rat leiomyoma cells and late pregnant rat myometrium, the release of S1P involves a similar signalling pathway and occurs through ABCC1.
鞘氨醇 1-磷酸(S1P)是一种由鞘氨醇激酶(SphK1/2)生成的生物活性脂质,可启动涉及生理和病理过程的不同信号通路。我们之前的研究表明,在妊娠晚期(第 19 天)的大鼠子宫平滑肌中,SphK1 通过生成和释放 S1P 增加 COX2 的表达。在大鼠子宫肌瘤细胞(ELT3)中,SphK1/S1P 轴控制细胞的存活和增殖。在本研究中,我们证明 PDBu 激活 SphK1 而不激活 SphK2。SphK1 的激活需要 PKC 和 MAPK ERK1/2。PDBu 产生的 S1P 释放到培养基中。PKC 抑制剂 Ro-318220 和 BIM、MEK 抑制剂 U0126 和 PD98059、SphKI/2 抑制剂 SKI-II 和 SphK1-siRNA 均可消除 PDBu 诱导的 S1P 外排,提示 PKC、ERK 和 SphK1 分别参与了这一过程。S1P 的释放对 ABCA1 和 ABCB1 转运体抑制剂不敏感,但当 ABCC1 转运体被 MK571 抑制或用 ABCC1-siRNA 下调时,S1P 的释放被消除。PDBu 增加 COX2 的表达,这种增加可被 PKC、ERK1/2、SphK1 的抑制以及用 MK571 处理或用 ABCC1-siRNA 转染所阻断。由于 PDBu 或外源性 S1P 释放引起的 COX2 诱导涉及与 Gi 偶联的 S1P2 受体。在妊娠晚期的大鼠子宫平滑肌中,当 SphK 和 ABCC1 被抑制时,S1P 的释放也被强烈减少。这些数据表明,在大鼠子宫肌瘤细胞和妊娠晚期大鼠子宫平滑肌中,S1P 的释放涉及相似的信号通路,并通过 ABCC1 发生。